Drugs / Demineralized Dentin Matrix
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07239193 | Dec 2025 → Jul 2026 overdue | — | Cairo University | Not yet recruiting | No outcome recorded |
| — | NCT06318650 | Feb → Jun 2024 | — | Cairo University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Demineralized Dentin Matrix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06318650 ↗ |
| Known as | DDM | “The first method utilizes Demineralized Dentin Matrix (DDM) prepared from the patient's own extracted tooth.” NCT07239193 ↗ |
| Modality | Other / unclassified | “Autogenous dentin-derived grafting material is used as a bone substitute for alveolar ridge preservation following molar extraction.” NCT07239193 ↗ |